UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN - DE 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 10
As coordinator: 2
As participant: 8
Sole participant: 0
Coordinator / Participant Ratio: 0.25*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 7.126.244 22.810.916 3.190.370 1 2
2022 1.500.000 9.250.101 2.221.350 1 2
2021 0 2.413.400 877.338 1
2020 0 13.998.127 359.603 2
2019 0 20.997.523 2.247.065 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL7
MEDIZINISCHE UNIVERSITAT GRAZ3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS2
LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
THE UNIVERSITY OF MANCHESTER2
UNIVERSITAET ZU LUEBECK2
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF2
UNIVERSITY OF CAMBRIDGE2
ABBVIE INC1
ACADEMISCH ZIEKENHUIS GRONINGEN1
AINIGMA TECHNOLOGIES1
ARTTIC INNOVATION1
ASOCIACION PARKINSON MADRID1
ASSOCIATION GERCOR1
ASTRAZENECA1
BEIA CONSULT INTERNATIONAL1
BIOGEN IDEC LIMITED1
BIOXPEDIA AS1
BYTEFLIES1
CAMBRIDGE COGNITION LIMITED1
CARR COMMUNICATIONS LIMITED1
CATALINK LIMITED1
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CINEMARE UG1
CITTI HANDELSGESELLSCHAFT MBH & CO KG1
COLLECTIVE MINDS RADIOLOGY AB1
CONCENTRIS RESEARCH MANAGEMENT1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
DE MONTFORT UNIVERSITY1
DEUTSCHE ZENTRALBIBLIOTHEK FUER WIRTSCHAFTSWISSENSCHAFTEN LEIBNIZ INFORMATIONSZENTRUM WIRTSCHAFT1
DIN DEUTSCHES INSTITUT FUER NORMUNG EV1
DREEM1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
ELI LILLY AND COMPANY LIMITED1
ELLINIKI ETAIREIA OGKOLOGIAS PEPTIKOU1
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH1
EREVNITIKO PANEPISTIMIAKO INSTITOUTO SYSTIMATON EPIKOINONION KAI YPOLGISTONEMP1
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE1
EUROPACOLON PORTUGAL ASSOCIACAO DE LUTA CONTRA O CANCRO DO INTESTINO1
EUROPAISCHE VEREINIGUNG DER GASTROINTESTINALEN ONKOLOGIE1
EUROPAUNION DEUTSCHLAND LANDESVERBAND SCHLESWIGHOLSTEIN EV1
EUROPEAN CANCER PATIENT COALITION1
EXUS SOFTWARE MONOPROSOPI ETAIRIA PERIORISMENIS EVTHINIS1
EY ADVISORY1
F HOFFMANNLA ROCHE1
FACHHOCHSCHULE KIEL1
FCIENCIASID ASSOCIACAO PARA A INVESTIGACAO E DESENVOLVIMENTO DE CIENCIAS1
FEDERAZIONE ITALIANA DELLE ASSOCIAZIONI DI VOLONTARIATO IN ONCOLOGIA1
FIRALIS1
FONDAZIONE DEL PIEMONTE PER L'ONCOLOGIA1
FREIE UNIVERSITAET BERLIN1
FRIEDRICH SCHILLER UNIVERSITAET JENA1
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG1
FUDAN UNIVERSITY1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL1
FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III1
FUNDATIA YOUTH CANCER EUROPE1
GEORGEHUNTINGTONINSTITUT1
GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION INC1
GIE AXA1
GOOGLE LLC1
GREEN SCREEN FESTIVAL EV1
GROUPE DES ECOLES DES TELECOMMUNICATIONS1
GROUPEMENT EUROPEEN D INTERET ECONOMIQUE ORGANISATION OF EUROPEAN CANCER INSTITUTES OECI1
HELMHOLTZZENTRUM FUR OZEANFORSCHUNG KIEL1
HELSE STAVANGER HF1
ICELLATE MEDICAL AB1
IMMUNOVIA AB1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INNOVATION SPRINT1
INSTITUT FUER QUALITAETSENTWICKLUNG AN SCHULEN SCHLESWIGHOLSTEIN1
INSTITUT FUR WELTWIRTSCHAFT1
INSTITUT GUSTAVE ROUSSY1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTE OF PSYCHIATRY AND NEUROLOGY1
INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA1
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES1
INSTITUTO PORTUGUES DE ONCOLOGIA DO PORTO FRANCISCO GENTIL EPE1
INSTITUTUL ONCOLOGIC PROF DR ALEXANDRU TRESTIOREANU BUCURESTI1
INSTITUTUL ONCOLOGIC PROF DR ION CHIRICUTA CLUJNAPOCA1
INTERNATIONAL PREVENTION RESEARCH INSTITUTIPRI MANAGEMENT1
INVESTITIONSBANK SCHLESWIGHOLSTEIN1
IXSCIENT LIMITED1
JANSSEN PHARMACEUTICA NV1
KAROLINSKA INSTITUTE1
KIEL REGION1
KING'S COLLEGE LONDON1
KONNEKT ABLE TECHNOLOGIES LIMITED1
KSILINK1
LANDESHAUPTSTADT KIEL1
LEIBNIZINSTITUT FUR DIE PADAGOGIKDER NATURWISSENSCHAFTEN UND MATHEMATIK AN DER UNIVERSITAT KIEL1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA1

Constancy:

Total number of partners: 194
Partner loyalty:
Frequent Partner: (> 2 projects): 10
Rare Partner: 184
Frequent / Rare Partner Ratio: 0.05

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01A European “shield” against colorectal cancer based on novel, more precise and affordable risk-based screening methods and viable policy pathways ONCOSCREENparticipant12.972.07640
2023-01-01Personalised blueprint intestinal health miGut-Healthcoordinator7.126.24412
2023-01-01PANcreatic CAncer Initial Detection via liquid biopsy PANCAIDparticipant9.838.84019
2022-07-01Microbiota-T cell interactions - antigen-specificity and regulation in health and disease MicroTcoordinator1.500.0002
2022-06-01Reducing the impact of major environmental challenges on mental health environMENTALparticipant9.045.28824
2022-03-01Festival der Wissenschaft Kiel Region 2022/2023 SCIENCE4FUTUREparticipant204.81322
2021-07-01The first multi-cancer liquid biopsy test for detection of early-stage cancer and minimal residual disease from a blood draw DeteCTCsparticipant2.413.4004
2020-01-01Integrated and standardized NGS workflows for Personalised therapy Instand-NGS4Pparticipant10.998.12822
2020-01-01Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. NeutroCureparticipant2.999.99912
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52347